Assignee
ASARINA PHARMA AB
SE·4 granted patents·3 pending applications·0 citations·filing 2017–2024
Top patents by PatentIndex Score
7 records- 0176US2023117905A1Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesASARINA PHARMA AB·Filed 2022·Application pending·0 cites
- 0273US2025041206A1Injectable SuspensionsASARINA PHARMA AB·Filed 2024·Application pending·0 cites
- 0365US10933014B2Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereofASARINA PHARMA AB·Filed 2018·Granted Mar 2, 2021·0 cites·9 claims
- 0460US11534446B2Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesASARINA PHARMA AB·Filed 2017·Granted Dec 27, 2022·0 cites·19 claims
- 0560US2021100736A1Injectable SuspensionsASARINA PHARMA AB·Filed 2020·Application pending·0 cites
- 0656US11026953B23-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremorASARINA PHARMA AB·Filed 2018·Granted Jun 8, 2021·0 cites·7 claims
- 0749US11026954B23-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatmentASARINA PHARMA AB·Filed 2018·Granted Jun 8, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when ASARINA PHARMA AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →